SEI Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,835
Closed -$260K 2483
2020
Q3
$260K Sell
1,835
-2,432
-57% -$405K ﹤0.01% 2147
2020
Q2
$842K Sell
4,267
-2,764
-39% -$572K ﹤0.01% 1624
2020
Q1
$1.38M Sell
7,031
-1,994
-22% -$429K 0.01% 1313
2019
Q4
$1.87M Buy
9,025
+2,371
+36% +$438K 0.01% 1368
2019
Q3
$1.02M Sell
6,654
-5,878
-47% -$963K ﹤0.01% 1596
2019
Q2
$1.62M Buy
12,532
+1,773
+16% +$210K 0.01% 1411
2019
Q1
$1.27M Buy
10,759
+10,731
+38,325% +$1.08M ﹤0.01% 1503
2018
Q4
$3K Hold
28
﹤0.01% 2604
2018
Q3
$3K Buy
+28
New +$2.96K ﹤0.01% 2472

Other funds holding LKFT

SEI Investments's LKFT Position: Q4 2020 in Review

SEI Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 1,835 shares — an estimated $260K sold.

SEI Investments first reported a position in LKFT in Q3 2018 and held it in 9 quarters. The position peaked at $1.87M in Q4 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • SEI Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • SEI Investments sold 1,835 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $260K.
  • SEI Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 9 quarters.
  • SEI Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.87M in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.